{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:46:35Z","timestamp":1782571595499,"version":"3.54.5"},"reference-count":105,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Friends of Garrett Cumming Research Chair Fund","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"HM Toupin Neurological Science Research Chair Fund","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"DOI":"10.13039\/501100000223","name":"Muscular Dystrophy Canada","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100000223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN 143251"],"award-info":[{"award-number":["FDN 143251"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Alberta Faculty of Medicine and Dentistry","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010090","name":"Women and Children's Health Research Institute","doi-asserted-by":"publisher","award":["IG 2874"],"award-info":[{"award-number":["IG 2874"]}],"id":[{"id":"10.13039\/100010090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive condition caused primarily by out-of-frame mutations in the dystrophin gene. In males, DMD presents with progressive body-wide muscle deterioration, culminating in death as a result of cardiac or respiratory failure. A milder form of DMD exists, called Becker muscular dystrophy (BMD), which is typically caused by in-frame dystrophin gene mutations. It should be emphasized that DMD and BMD are not exclusive to males, as some female dystrophin mutation carriers do present with similar symptoms, generally at reduced levels of severity. Cardiac involvement in particular is a pressing concern among manifesting females, as it may develop into serious heart failure or could predispose them to certain risks during pregnancy or daily life activities. It is known that about 8% of carriers present with dilated cardiomyopathy, though it may vary from 0% to 16.7%, depending on if the carrier is classified as having DMD or BMD. Understanding the genetic and molecular mechanisms underlying cardiac manifestations in dystrophin-deficient females is therefore of critical importance. In this article, we review available information from the literature on this subject, as well as discuss the implications of female carrier studies on the development of therapies aiming to increase dystrophin levels in the heart.<\/jats:p>","DOI":"10.3390\/genes11070765","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T09:45:31Z","timestamp":1594374331000},"page":"765","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-4183","authenticated-orcid":false,"given":"Kenji Rowel Q.","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narin","family":"Sheri","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1330-9026","authenticated-orcid":false,"given":"Quynh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G2H7, Canada"},{"name":"The Friends of Garrett Cumming Research &amp; Muscular Dystrophy Canada HM Toupin Neurological Science Research Chair, Edmonton, AB T6G2H7, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases-a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.23528","article-title":"Evidence-based path to newborn screening for Duchenne muscular dystrophy","volume":"71","author":"Mendell","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/adc.2007.118141","article-title":"Update on the management of Duchenne muscular dystrophy","volume":"93","author":"Manzur","year":"2008","journal-title":"Arch. Dis. Child."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2147\/NDT.S93873","article-title":"Current and emerging treatment strategies for Duchenne muscular dystrophy","volume":"12","author":"Mah","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/364725a0","article-title":"Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity","volume":"364","author":"Cox","year":"1993","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5582\/irdr.2017.01024","article-title":"Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series","volume":"6","author":"Papa","year":"2017","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0003-3995(01)01084-X","article-title":"Carrier detection and prenatal molecular diagnosis in a Duchenne muscular dystrophy family without any affected relative available","volume":"44","author":"Angel","year":"2001","journal-title":"Ann. G\u00e9n\u00e9tique"},{"key":"ref_12","first-page":"179","article-title":"Risk assessment and genetic counseling in families with Duchenne muscular dystrophy","volume":"31","author":"Grimm","year":"2012","journal-title":"Acta Myol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0960-8966(99)00018-8","article-title":"Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy","volume":"9","author":"Hoogerwaard","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nmd.2010.05.010","article-title":"Clinical and genetic characterization of manifesting carriers of DMD mutations","volume":"20","author":"Soltanzadeh","year":"2010","journal-title":"Neuromuscul. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00439-016-1666-6","article-title":"Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy","volume":"135","author":"Viggiano","year":"2016","journal-title":"Hum. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2013.09.036","article-title":"Symptomatic female carriers of Duchenne muscular dystrophy (DMD): Genetic and clinical characterization","volume":"336","author":"Giliberto","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2169\/internalmedicine.39.2","article-title":"Cardiac Involvement of Female Carrier of Duchenne Muscular Dystrophy","volume":"39","author":"Kamakura","year":"2000","journal-title":"Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","article-title":"Female dystrophinopathy: Review of current literature","volume":"28","author":"Ishizaki","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_19","first-page":"1590","article-title":"Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy","volume":"131","author":"Nally","year":"2015","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","article-title":"All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy","volume":"61","author":"Schram","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_21","first-page":"128","article-title":"Management of cardiac involvement in muscular dystrophies: Paediatric versus adult forms","volume":"35","author":"Palladino","year":"2016","journal-title":"Acta Myol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-Deficient Cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mah, M.L., Cripe, L., Slawinski, M.K., Al-Zaidy, S.A., Camino, E., Lehman, K.J., Jackson, J.L., Iammarino, M., Miller, N., and Mendell, J.R. (2020). Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing. Int. J. Cardiol., in press.","DOI":"10.1016\/j.ijcard.2020.05.052"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2018.03.015","article-title":"Muscle, cardiac, and cerebral manifestations in female carriers of dystrophin variants","volume":"388","author":"Finsterer","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1002\/ajmg.a.33784","article-title":"Childhood onset of left ventricular dysfunction in a female manifesting carrier of muscular dystrophy","volume":"155","author":"Martinez","year":"2011","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/CND.0b013e3181adcda7","article-title":"Congestive Heart Failure With Rhabdomyolysis and Acute Renal Failure in a Manifesting Female Carrier of Duchenne Muscular Dystrophy With Duplication of Dystrophin Gene","volume":"11","author":"Tunteeratum","year":"2009","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijcard.2008.06.084","article-title":"Cardiac involvement in a female carrier of Duchenne muscular dystrophy","volume":"138","author":"Walcher","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0960-8966(98)00071-6","article-title":"Cardiac transplantation in a Duchenne muscular dystrophy carrier","volume":"8","author":"Melacini","year":"1998","journal-title":"Neuromuscul. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0140-6736(92)92942-9","article-title":"Myocardial evidence of dystrophin mosaic in a Duchenne muscular dystrophy carrier","volume":"340","author":"Fischer","year":"1992","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/hmg\/ddh174","article-title":"Full-length dystrophin expression in half of the heart cells ameliorates -isoproterenol-induced cardiomyopathy in mdx mice","volume":"13","author":"Yue","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_31","first-page":"171","article-title":"Mosaic expression of dystrophin in carriers of canine X-linked muscular dystrophy","volume":"62","author":"Cooper","year":"1990","journal-title":"Lab. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.rvsc.2012.09.027","article-title":"Cardiac structure and function in female carriers of a canine model of Duchenne muscular dystrophy","volume":"94","author":"Kane","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pediatrneurol.2015.11.004","article-title":"Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne\/Becker Muscular Dystrophy","volume":"55","author":"Papa","year":"2016","journal-title":"Pediatr. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/ajmg.a.32808","article-title":"Homozygous female Becker muscular dystrophy","volume":"149A","author":"Fujii","year":"2009","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/hrt.2003.023390","article-title":"Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy","volume":"90","author":"Cohen","year":"2004","journal-title":"Heart"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/ph8020303","article-title":"X-linked dilated cardiomyopathy: A cardiospecific phenotype of dystrophinopathy","volume":"8","author":"Nakamura","year":"2015","journal-title":"Pharmaceuticals"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1161\/01.CIR.87.6.1854","article-title":"X-linked dilated cardiomyopathy: Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus","volume":"87","author":"Towbin","year":"1993","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1073\/pnas.50.3.481","article-title":"Demonstration of two populations of cells in the human female heterozygous for glucose-6-phosphate dehydrogenase variants","volume":"50","author":"Davidson","year":"1963","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00207374","article-title":"X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: Concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes","volume":"96","author":"Azofeifa","year":"1995","journal-title":"Hum. Genet."},{"key":"ref_40","first-page":"672","article-title":"Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy","volume":"46","author":"Richards","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1399-0004.1998.tb02655.x","article-title":"Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy","volume":"53","author":"Yoshioka","year":"2008","journal-title":"Clin. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1086\/518369","article-title":"Defining the Cause of Skewed X-Chromosome Inactivation in X-Linked Mental Retardation by Use of a Mouse Model","volume":"80","author":"Muers","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ajmg.1320430619","article-title":"X inactivation and dystrophin studies in a t(X;12) female: Evidence for biochemical normalization in Duchenne muscular dystrophy carriers","volume":"43","author":"Wenger","year":"1992","journal-title":"Am. J. Med. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00270570","article-title":"Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome","volume":"67","author":"Freund","year":"1984","journal-title":"Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ajmg.1320400411","article-title":"Uniparental disomy, isodisomy, and imprinting: Probable effects in man and strategies for their detection","volume":"40","author":"Engel","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"ref_46","first-page":"160","article-title":"Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy","volume":"60","author":"Quan","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00282093","article-title":"De novo DNA microdeletion in a girl with Turner syndrome and Duchenne muscular dystrophy","volume":"74","author":"Chelly","year":"1986","journal-title":"Hum. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/000992280604500402","article-title":"Turner Syndrome: An Update and Review for the Primary Pediatrician","volume":"45","author":"Doswell","year":"2006","journal-title":"Clin. Pediatr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1620\/tjem.222.149","article-title":"Duchenne muscular dystrophy in a female patient with a karyotype of 46,X,i(X)(q10)","volume":"222","author":"Ou","year":"2010","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00439-006-0159-4","article-title":"Co-occurrence of mutations in both dystrophin- and androgen-receptor genes is a novel cause of female Duchenne muscular dystrophy","volume":"119","author":"Katayama","year":"2006","journal-title":"Hum. Genet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1096-8628(19960503)63:1<223::AID-AJMG39>3.0.CO;2-O","article-title":"Phenotypic classification of male pseudohermaphroditism due to steroid 5\u03b1-reductase 2 deficiency","volume":"63","author":"Sinnecker","year":"1996","journal-title":"Am. J. Med. Genet."},{"key":"ref_52","first-page":"264","article-title":"Androgen receptor locus on the human X chromosome: Regional localization to Xq11-12 and description of a DNA polymorphism","volume":"44","author":"Brown","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Nguyen, Q., Lim, K.R.Q., and Yokota, T. (2020). Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030733"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Lim, K.R.Q., Yoon, C., and Yokota, T. (2018). Applications of CRISPR\/Cas9 for the Treatment of Duchenne Muscular Dystrophy. J. Pers. Med., 8.","DOI":"10.20944\/preprints201811.0018.v1"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"175628641983347","DOI":"10.1177\/1756286419833478","article-title":"Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies","volume":"12","author":"Piga","year":"2019","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JND-150133","article-title":"Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?","volume":"3","author":"Kalra","year":"2016","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2010.06.024","article-title":"Female Human iPSCs Retain an Inactive X Chromosome","volume":"7","author":"Tchieu","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_58","first-page":"1","article-title":"Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status","volume":"2017","author":"Nishiyama","year":"2017","journal-title":"Stem Cells Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/jcmm.14124","article-title":"Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients","volume":"23","author":"Eisen","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fpsyt.2012.00024","article-title":"X-Chromosome Inactivation in Rett Syndrome Human Induced Pluripotent Stem Cells","volume":"3","author":"Cheung","year":"2012","journal-title":"Front. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.stemcr.2014.12.012","article-title":"Stable X Chromosome Reactivation in Female Human Induced Pluripotent Stem Cells","volume":"4","author":"Barakat","year":"2015","journal-title":"Stem Cell Reports"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.stem.2012.02.014","article-title":"Erosion of Dosage Compensation Impacts Human iPSC Disease Modeling","volume":"10","author":"Mekhoubad","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"eaap9004","DOI":"10.1126\/sciadv.aap9004","article-title":"Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing","volume":"4","author":"Long","year":"2018","journal-title":"Sci. Adv."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1126\/science.2662404","article-title":"The molecular basis of muscular dystrophy in the mdx mouse: A point mutation","volume":"244","author":"Sicinski","year":"1989","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.107.162982","article-title":"Prevention of Dystrophin-Deficient Cardiomyopathy in Twenty-One-Month-Old Carrier Mice by Mosaic Dystrophin Expression or Complementary Dystrophin\/Utrophin Expression","volume":"102","author":"Bostick","year":"2008","journal-title":"Circ. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/hmg\/ddaa015","article-title":"DMD carrier model with mosaic dystrophin expression in the heart reveals complex vulnerability to myocardial injury","volume":"29","author":"Meyers","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/jcsm.12506","article-title":"Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology","volume":"11","author":"Westering","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"van Putten, M., Hulsker, M., Nadarajah, V.D., van Heiningen, S.H., van Huizen, E., van Iterson, M., Admiraal, P., Messemaker, T., den Dunnen, J.T., and \u2019t Hoen, P.A.C. (2012). The Effects of Low Levels of Dystrophin on Mouse Muscle Function and Pathology. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031937"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2014.01.009","article-title":"Low dystrophin levels in heart can delay heart failure in mdx mice","volume":"69","author":"Hulsker","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1096\/fj.12-224170","article-title":"Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin\/utrophin double-knockout mice","volume":"27","author":"Hulsker","year":"2013","journal-title":"FASEB J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/stem.2518","article-title":"Small Fractions of Muscular Dystrophy Embryonic Stem Cells Yield Severe Cardiac and Skeletal Muscle Defects in Adult Mouse Chimeras","volume":"35","author":"Gonzalez","year":"2017","journal-title":"Stem Cells"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/mus.21763","article-title":"Gender influences cardiac function in the mdx model of duchenne cardiomyopathy","volume":"42","author":"Bostick","year":"2010","journal-title":"Muscle Nerve"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1096\/fj.06-7353com","article-title":"Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma","volume":"21","author":"Chamberlain","year":"2007","journal-title":"FASEB J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1096\/fj.201802488R","article-title":"Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy","volume":"33","author":"Putker","year":"2019","journal-title":"FASEB J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yjmcc.2016.11.011","article-title":"Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy","volume":"102","author":"Wasala","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/hmg\/10.6.581","article-title":"Primary non-random X inactivation associated with disruption of Xist promoter regulation","volume":"10","author":"Newall","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","article-title":"Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy","volume":"90","author":"Deconinck","year":"1997","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","article-title":"Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy","volume":"90","author":"Grady","year":"1997","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0022-510X(93)90190-A","article-title":"Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects","volume":"119","author":"Mizuno","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Stillwell, E., Vitale, J., Zhao, Q., Beck, A., Schneider, J., Khadim, F., Elson, G., Altaf, A., Yehia, G., and Dong, J. (2009). Blastocyst Injection of Wild Type Embryonic Stem Cells Induces Global Corrections in Mdx Mice. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004759"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ehjci\/jev161","article-title":"Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: A comparative cardiovascular magnetic resonance study","volume":"17","author":"Florian","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/WCO.0000000000000240","article-title":"Modifier genes and their effect on Duchenne muscular dystrophy","volume":"28","author":"Vo","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ng0593-87","article-title":"New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin","volume":"4","author":"Cox","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/hmg\/5.8.1149","article-title":"Differential expression of dystrophin isoforms in strains of mdx mice with different mutations","volume":"5","author":"Im","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Li, D., Yue, Y., and Duan, D. (2010). Marginal Level Dystrophin Expression Improves Clinical Outcome in a Strain of Dystrophin\/Utrophin Double Knockout Mice. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015286"},{"key":"ref_86","first-page":"346","article-title":"Cardiomyopathy in Dystrophin-Deficient Hypertrophic Feline Muscular Dystrophy","volume":"13","author":"Gaschen","year":"1999","journal-title":"J. Vet. Intern. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0735-1097(10)80202-5","article-title":"Duchenne\u2019s cardiomyopathy in a canine model: Electrocardiographic and echocardiographic studies","volume":"17","author":"Moise","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_88","first-page":"1202","article-title":"Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"11","author":"Nguyen","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Hakim, C.H., Wasala, N.B., Nelson, C.E., Wasala, L.P., Yue, Y., Louderman, J.A., Lessa, T.B., Dai, A., Zhang, K., and Jenkins, G.J. (2018). AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice. JCI Insight, 3.","DOI":"10.1172\/jci.insight.124297"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ymthe.2019.05.001","article-title":"Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice","volume":"27","author":"Xu","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ebiom.2019.06.036","article-title":"Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases","volume":"45","author":"Tsoumpra","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/mt.2008.120","article-title":"Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice","volume":"16","author":"Jearawiriyapaisarn","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8986","DOI":"10.1038\/srep08986","article-title":"Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice","volume":"5","author":"Betts","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/cvr\/cvp335","article-title":"Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers","volume":"85","author":"Jearawiriyapaisarn","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1073\/pnas.1613203114","article-title":"Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy","volume":"114","author":"Echigoya","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_98","first-page":"179","article-title":"Optimizing exon skipping therapies for DMD","volume":"26","author":"Yokota","year":"2007","journal-title":"Acta Myol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Echigoya, Y., Lim, K.R.Q., Nakamura, A., and Yokota, T. (2018). Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges. J. Pers. Med., 8.","DOI":"10.3390\/jpm8040041"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1172-7-45","article-title":"Assessment of the structural and functional impact of in-frame mutations of the DMD gene, using the tools included in the eDystrophin online database","volume":"7","author":"Nicolas","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Friedrich, O., von Wegner, F., Chamberlain, J.S., Fink, R.H.A., and Rohrbach, P. (2008). L-Type Ca2+ Channel Function Is Linked to Dystrophin Expression in Mammalian Muscle. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001762"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1009805419285","article-title":"Dystrophin and the Cardiomyocyte Membrane Cytoskeleton in the Healthy and Failing Heart","volume":"5","author":"Kaprielian","year":"2000","journal-title":"Heart Fail. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1113\/jphysiol.2011.210989","article-title":"Calcium controls cardiac function\u2014by all means!","volume":"589","author":"Sejersted","year":"2011","journal-title":"J. Physiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1538\/expanim.62.211","article-title":"Subcellular Localization of Dystrophin Isoforms in Cardiomyocytes and Phenotypic Analysis of Dystrophin-deficient Mice Reveal Cardiac Myopathy is Predominantly Caused by a Deficiency in Full-length Dystrophin","volume":"62","author":"Masubuchi","year":"2013","journal-title":"Exp. Anim."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/WNL.45.4.677","article-title":"Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: Evidence for failure of dystrophin production in dystrophin-competent myonuclei","volume":"45","author":"Pegoraro","year":"1995","journal-title":"Neurology"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/11\/7\/765\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:48:47Z","timestamp":1760176127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/11\/7\/765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":105,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["genes11070765"],"URL":"https:\/\/doi.org\/10.3390\/genes11070765","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]}}}